200 related articles for article (PubMed ID: 33995277)
61. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
Dekkers T; ter Meer M; Lenders JW; Hermus AR; Schultze Kool L; Langenhuijsen JF; Nishimoto K; Ogishima T; Mukai K; Azizan EA; Tops B; Deinum J; Küsters B
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1341-51. PubMed ID: 24758183
[TBL] [Abstract][Full Text] [Related]
62. I-131 NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism.
Kao CH; Liao SQ; Wang SJ; Lin MS; Hsu CY; Lin WY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Apr; 8(4):213-8. PubMed ID: 1578517
[TBL] [Abstract][Full Text] [Related]
63. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.
Azizan EA; Murthy M; Stowasser M; Gordon R; Kowalski B; Xu S; Brown MJ; O'Shaughnessy KM
Hypertension; 2012 Mar; 59(3):587-91. PubMed ID: 22252394
[TBL] [Abstract][Full Text] [Related]
64. An update on novel mechanisms of primary aldosteronism.
Zennaro MC; Boulkroun S; Fernandes-Rosa F
J Endocrinol; 2015 Feb; 224(2):R63-77. PubMed ID: 25424518
[TBL] [Abstract][Full Text] [Related]
65. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.
Nanba K; Yamazaki Y; Bick N; Onodera K; Tezuka Y; Omata K; Ono Y; Blinder AR; Tomlins SA; Rainey WE; Satoh F; Sasano H
J Clin Endocrinol Metab; 2020 Nov; 105(11):e4066-73. PubMed ID: 32844168
[TBL] [Abstract][Full Text] [Related]
66. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
Mulatero P; Tauber P; Zennaro MC; Monticone S; Lang K; Beuschlein F; Fischer E; Tizzani D; Pallauf A; Viola A; Amar L; Williams TA; Strom TM; Graf E; Bandulik S; Penton D; Plouin PF; Warth R; Allolio B; Jeunemaitre X; Veglio F; Reincke M
Hypertension; 2012 Feb; 59(2):235-40. PubMed ID: 22203740
[TBL] [Abstract][Full Text] [Related]
67. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
[TBL] [Abstract][Full Text] [Related]
68. Adrenalectomy Completely Cured Hypertension in Patients With Familial Hyperaldosteronism Type I Who Had Somatic KCNJ5 Mutation.
Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chueh JS; Wu KD
J Clin Endocrinol Metab; 2019 Nov; 104(11):5462-5466. PubMed ID: 31287546
[TBL] [Abstract][Full Text] [Related]
69. 131I-6β-iodomethyl-19-norcholesterol adrenal scintigraphy as an alternative to adrenal venous sampling in differentiating aldosterone-producing adenoma from bilateral idiopathic hyperaldosteronism.
Saiga A; Yokota H; Nagano H; Sawada K; Kubota Y; Wada T; Horikoshi T; Tanaka T; Uno T
Nucl Med Commun; 2020 Dec; 41(12):1226-1233. PubMed ID: 32956247
[TBL] [Abstract][Full Text] [Related]
70. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome].
Sialer G; Marincek B; Mengden T; Vetter W
Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253
[TBL] [Abstract][Full Text] [Related]
71. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
[TBL] [Abstract][Full Text] [Related]
72. NP-59 test for preoperative localization of primary hyperaldosteronism.
Di Martino M; García Sanz I; Muñoz de Nova JL; Marín Campos C; Martínez Martín M; Domínguez Gadea L
Langenbecks Arch Surg; 2017 Mar; 402(2):303-308. PubMed ID: 28224279
[TBL] [Abstract][Full Text] [Related]
73. Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.
Ono Y; Yamazaki Y; Omata K; Else T; Tomlins SA; Rhayem Y; Williams TA; Reincke M; Carling T; Monticone S; Mulatero P; Beuschlein F; Ito S; Satoh F; Rainey WE; Sasano H
J Clin Endocrinol Metab; 2020 Mar; 105(3):e282-9. PubMed ID: 31789380
[TBL] [Abstract][Full Text] [Related]
74. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
Gao X; Yamazaki Y; Tezuka Y; Onodera Y; Ogata H; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
J Steroid Biochem Mol Biol; 2019 Oct; 193():105434. PubMed ID: 31351131
[TBL] [Abstract][Full Text] [Related]
75. Aldosterone-Producing Adenoma With a Somatic KCNJ5 Mutation Revealing APC-Dependent Familial Adenomatous Polyposis.
Vouillarmet J; Fernandes-Rosa F; Graeppi-Dulac J; Lantelme P; Decaussin-Petrucci M; Thivolet C; Peix JL; Boulkroun S; Clauser E; Zennaro MC
J Clin Endocrinol Metab; 2016 Nov; 101(11):3874-3878. PubMed ID: 27648962
[TBL] [Abstract][Full Text] [Related]
76. Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI.
Lumachi F; Marzola MC; Zucchetta P; Tregnaghi A; Cecchin D; Favia G; Bui F
Nucl Med Commun; 2003 Jun; 24(6):683-8. PubMed ID: 12766605
[TBL] [Abstract][Full Text] [Related]
77. Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism?
Spyridonidis TJ; Apostolopoulos DJ
Hell J Nucl Med; 2013; 16(2):134-9. PubMed ID: 23865085
[TBL] [Abstract][Full Text] [Related]
78. Primary aldosteronism and potassium channel mutations.
Stowasser M
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):170-9. PubMed ID: 23426162
[TBL] [Abstract][Full Text] [Related]
79. Genetics of primary aldosteronism.
Funder JW
Front Horm Res; 2014; 43():70-8. PubMed ID: 24943299
[TBL] [Abstract][Full Text] [Related]
80. Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations.
Lim JS; Plaska SW; Rege J; Rainey WE; Turcu AF
Front Endocrinol (Lausanne); 2021; 12():644382. PubMed ID: 33796077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
